Received Feb 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 1 | Y009782 | IM / LA |
There is no adverse event reported at this time; however, it was discovered that the vaccine was given too early. Patient received Varivax on 12/27/24 (it had not been 28 days between this vaccine and the dose of M-M-R given on 1/2/25). This was discovered when the patient came in on 2/23/25 for a second dose of Varivax. No adverse effects were reported.
None reported
None reported
None.
Latex